MedTrace Logo

Clinical Outcome and Cytokine Expression After TKA

NCT03424174 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-07

No results posted yet for this study

Summary

Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results

Conditions

Interventions

DEVICE

Coated Total Knee Arthroplasty

Implantation coated Total Knee Arthroplasty

DEVICE

Standard Total Knee Arthroplasty

Implantation StandardTotal Knee Arthroplasty

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Jörg Lützner, MD · University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-04
Primary Completion
2023-12-31
Completion
2028-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424174 on ClinicalTrials.gov